Home Newsfeeds B of A Securities Downgrades Baxter Intl to Neutral, Announces $55 Price Target

B of A Securities Downgrades Baxter Intl to Neutral, Announces $55 Price Target

B of A Securities analyst Travis Steed downgrades Baxter Intl (NYSE:BAX) from Buy to Neutral and announces $55 price target.

byBenzinga Newsdesk

January 3, 2023

1 minute read

B of A Securities analyst Travis Steed downgrades Baxter Intl (NYSE:BAX) from Buy to Neutral and announces $55 price target.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,900 Today

By Benzinga Insights

December 25, 1:00 PM

Hilton Worldwide Holdings (NYSE:HLT) has outperformed the market over the past 10 years by 4.76% on an annualized…

HLT

Ulta Beauty Q1 Earnings Preview: Positive Foot Traffic Data May Offset Concerns Over Same-Store Sales

By Chris Katje

May 29, 3:35 PM

Ulta Beauty has beaten analysts' estimates for revenue and earnings per share for more than 10 straight quarters. Will the trend continue?

ULTA

Why Cerevel Therapeutics Holdings Shares Are Nosediving

By Henry Khederian

November 8, 2:10 PM

Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 6.42% to $25.37 during Tuesday's session after the company reported worse-than-expected third-quarter EPS results and filed for a mixed-securities shelf offering of up to $900 million.

CERE